Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia

Acute myelogenous leukemia (AML) remains a serious fatal disease for the patients and effective treatment strategies are urgently needed. Based on the characteristics of the AML, we developed the CD44 and bone targeting liposomes delivery system decorated with the redox-cleavable polymer. First, ALN...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hao, Gao, Yuan, Ma, Jia, Hu, Maosong, Xia, Jing, Bao, Shuting, Liu, Yuxi, Feng, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469920/
https://www.ncbi.nlm.nih.gov/pubmed/36110161
http://dx.doi.org/10.1093/rb/rbac058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469920/
https://www.ncbi.nlm.nih.gov/pubmed/36110161
http://dx.doi.org/10.1093/rb/rbac058

Ejemplares similares